Quality of life (QOL) outcomes with cediranib/placebo in combination with carboplatin/paclitaxel (CP) in advanced non-small cell lung cancer (ANSCLC): results from NCIC CTG BR.24 Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Lee, Christopher W
  • Ding, Keyue
  • Le Maitre, Aurelie
  • Han, Lei
  • Laurie, Scott A
  • Goss, Glen
  • Shepherd, Frances A
  • Arnold, Andrew
  • Frymire, Eliot
  • Seymour, Lesley

publication date

  • September 1, 2009